06185 CANSINOBIO

Watchlist

33.150
-1.200-3.49%

Trading Mar 25 15:52 CST

8.20BMarket Cap-20.05P/E (TTM)

About CANSINOBIO Company

The company was founded in 2009 in China. It is an industry-leading high-tech biological products company with the mission of providing solutions for the prevention and treatment of infectious diseases worldwide, focusing on the R&D, production and commercialization of innovative, high-quality, and accessible human vaccines. Cansino Biotech's mission has always been to “provide the world with innovative, high-quality, and accessible vaccines” to achieve the corporate vision of “endless innovation, a world free of diseases”. The company is an innovative vaccine enterprise dedicated to the development, production and commercialization of innovative vaccines that meet Chinese and international standards. The marketed products and product pipeline cover the prevention of meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, shingles, tuberculosis, and many other vaccine varieties with high clinical demand. The main products are MCV4, MCV2, AD5-nCoV, inhaled AD5-nCoV and xBB.1.5 variant vaccines, AD5-eBoV, etc. Corporate honors: National High-tech Enterprise, Tianjin Key Laboratory for Respiratory Bacterial Recombination and Combined Vaccine Enterprises, Nankai University Talent Training Cooperation and Development Base, Tianjin Model Group, etc.

Company Profile

Symbol06185

Company NameCANSINOBIO

ISINCNE100003F01

Listing DateMar 28, 2019

Issue Price22.00

Shares Offered57.25M share(s)

FoundedJan 13, 2009

Registered AddressChina

ChairmanXuefeng YU

Secretaryjinzhaomingjing cui

Audit InstitutionDeloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)

Company CategoryOther

Registered Office401-420, 4th Floor, West District Biomedical Park, No. 185 South Street, West District, Tianjin Economic and Technological Development Zone

Head Office and Principal Place of BusinessRoom 1901, 19th floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong

Fiscal Year Ends12-31

Employees1494

MarketHong Kong motherboard

Phone022-58213766

Fax022-58213626

Emailir@cansinotech.com

Websitehttp://www.cansinotech.com.cn

BusinessLicense items: Class III medical device business; pharmaceutical production; pharmaceutical import and export; drug retail; pharmaceutical wholesale; import and export of goods; technology import and export. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to documents or licenses approved by relevant departments) General projects: Class I medical device sales; Class II medical device sales; medical research and experimental development; technical services, technology development, technical consultation, technology exchange, technology transfer, and technology promotion. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)

Company Executives

Name
Position
Salary

Xuefeng YU
Chairman of the Board, CEOs, Executive Director, General Manager, Member of the Remuneration and Assessment Committee, Nomination Committee Members, Authorized Representative
--

Shou Bai CHAO
Executive Director, Deputy General Manager, Chief Operating Officer
--

jing wang
Executive Director, Deputy General Manager, Chief Commercial Officer
--

shuifa gui
Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
--

jianzhong liu
Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members
--

yaoliang zhang
Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
--